Earnings4547KISSEI PHARMACEUTICAL CO.,LTD.
Kissei Pharmaceutical Reports Q1 Revenue of 23.4 billion, Up 5%
TOKYO, Jul 31 (Pulse News Wire) – Kissei Pharmaceutical Co., Ltd. (4547.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥23.4 billion (+5.4% YoY). operating profit was ¥1,095 million (-48.0%). net profit attributable to shareholders was ¥4,723 million (+4.5%).
Total assets stood at ¥270 billion with an equity ratio of 84.8%. The year-end dividend was set at ¥65 per share. The full-year forecast for the current fiscal year is revenue of ¥44.8 billion (-2.3%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥23,389M | +5.4% |
| Operating profit | ¥1,095M | -48.0% |
| Net profit | ¥4,723M | +4.5% |
Source: TDNet filing · Figures in millions of yen
End of article